GEFISTERIS 250

Gefitinib (250mg)

Introduction

Gefitinib 250mg, known as GEFISTERIS 250, is a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC). As a tyrosine kinase inhibitor, it specifically targets and inhibits the epidermal growth factor receptor (EGFR) involved in the growth and spread of cancer cells. This comprehensive guide provides detailed information on the uses, dosage, side effects, and pricing of GEFISTERIS 250 in India.

Uses

GEFISTERIS 250 is indicated for patients with non-small cell lung cancer that exhibits EGFR mutations. This targeted therapy works by blocking the EGFR, which plays a critical role in the growth and division of cancer cells. By inhibiting this receptor, gefitinib effectively slows down or halts the progression of cancer, providing significant therapeutic benefits to patients with specific genetic profiles. This precision medicine approach makes GEFISTERIS 250 a vital component of personalized cancer treatment plans.

Dosage

The standard dosage for GEFISTERIS 250 is one 250mg tablet per day. Patients are advised to take the tablet at the same time each day to maintain optimal drug levels in their bloodstream. The tablet can be ingested with or without food, but it should be swallowed whole with water, not chewed or crushed. In the event of a missed dose, it should be taken as soon as remembered unless the next scheduled dose is near. Patients should not double up on doses to compensate for a missed one. Consistency in taking the medication as prescribed is crucial for its effectiveness.

Side Effects

Patients taking GEFISTERIS 250 may experience a range of side effects. Common side effects include diarrhea, skin reactions (such as rash or dry skin), nausea, vomiting, and reduced appetite. Some individuals may encounter more serious side effects, including liver problems, severe gastrointestinal issues, or lung inflammation. Prompt communication with healthcare providers about any side effects is essential for managing and mitigating these reactions. Regular monitoring and supportive care can help alleviate the impact of side effects on patients' quality of life.

Price

In India, the cost of GEFISTERIS 250 can vary based on the supplier and pharmacy. Typically, a month's supply (30 tablets) is priced between INR 25,000 to INR 35,000. Patients are encouraged to explore different purchasing options and consider generic alternatives, which may offer the same therapeutic benefits at a lower cost.

Conclusion

GEFISTERIS 250 (Gefitinib 250mg) plays a critical role in the management of non-small cell lung cancer with EGFR mutations. Its targeted mechanism of action offers a focused approach to cancer treatment, minimizing harm to healthy cells and improving patient outcomes. Adherence to the prescribed dosage and regular consultations with healthcare providers are essential to maximize the benefits of this medication. With careful monitoring and management, GEFISTERIS 250 can be a cornerstone in the effective treatment of NSCLC, providing hope and improved quality of life for many patients. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma  Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information:

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

Buy Now: